Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Boeree

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 1, 2011
Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotypeAnita C Schürch, Kristin Kremer, Robin M Warren, et al.
Frontiers in Pharmacology|March 31, 2023
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.
Respiration; International Review of Thoracic Diseases|December 14, 2022
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for CliniciansJessica M Aguilar Diaz, Ahmed A Abulfathi, Lindsey Hm Te Brake, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2014
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T Ten Kate, Dick van Soolingen, et al.
International Journal of Antimicrobial Agents|March 25, 2008
Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicityAlma Tostmann, Martin J Boeree, Wilbert H M Peters, et al.
The Journal of Infection|June 20, 2024
Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcomeCynthia van Arkel, Iris Storms, Lisa Kurver, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2015
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T ten Kate, Dick van Soolingen, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 17, 2005
Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalenceDavid K Lewis, Christopher J M Whitty, Amanda L Walsh, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern TanzaniaJossy van den Boogaard, Hadija H Semvua, Jakko van Ingen, et al.
AIDS (London, England)|August 13, 2002
Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescenceMelita A Gordon, Hastings T Banda, Macpherson Gondwe, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 1, 2011
Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotypeAnita C Schürch, Kristin Kremer, Robin M Warren, et al.
Frontiers in Pharmacology|March 31, 2023
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug developmentRami Ayoun Alsoud, Robin J Svensson, Elin M Svensson, et al.
Respiration; International Review of Thoracic Diseases|December 14, 2022
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for CliniciansJessica M Aguilar Diaz, Ahmed A Abulfathi, Lindsey Hm Te Brake, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2014
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T Ten Kate, Dick van Soolingen, et al.
International Journal of Antimicrobial Agents|March 25, 2008
Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicityAlma Tostmann, Martin J Boeree, Wilbert H M Peters, et al.
The Journal of Infection|June 20, 2024
Elderly patients with tuberculosis in a low-incidence country - Clinical characteristics, inflammation and outcomeCynthia van Arkel, Iris Storms, Lisa Kurver, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2015
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T ten Kate, Dick van Soolingen, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 17, 2005
Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalenceDavid K Lewis, Christopher J M Whitty, Amanda L Walsh, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern TanzaniaJossy van den Boogaard, Hadija H Semvua, Jakko van Ingen, et al.
AIDS (London, England)|August 13, 2002
Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescenceMelita A Gordon, Hastings T Banda, Macpherson Gondwe, et al.
Pageof 13